- Home
- ORMP vs CTMX Comparison
ORMP vs CTMX Comparison
Compare ORMP & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- CTMX
- Stock Information
- Founded
- ORMP 2002
- CTMX 2008
- Country
- ORMP United States
- CTMX United States
- Employees
- ORMP N/A
- CTMX N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- ORMP Health Care
- CTMX Health Care
- Exchange
- ORMP Nasdaq
- CTMX Nasdaq
- Market Cap
- ORMP 90.2M
- CTMX 349.6M
- IPO Year
- ORMP N/A
- CTMX 2015
- Fundamental
- Price
- ORMP $2.32
- CTMX $1.99
- Analyst Decision
- ORMP Hold
- CTMX Strong Buy
- Analyst Count
- ORMP 1
- CTMX 3
- Target Price
- ORMP N/A
- CTMX $5.67
- AVG Volume (30 Days)
- ORMP 96.9K
- CTMX 2.7M
- Earning Date
- ORMP 11-06-2025
- CTMX 11-06-2025
- Dividend Yield
- ORMP N/A
- CTMX N/A
- EPS Growth
- ORMP N/A
- CTMX 263.20
- EPS
- ORMP N/A
- CTMX 0.49
- Revenue
- ORMP $2,000,000.00
- CTMX $141,100,000.00
- Revenue This Year
- ORMP N/A
- CTMX N/A
- Revenue Next Year
- ORMP N/A
- CTMX N/A
- P/E Ratio
- ORMP N/A
- CTMX $4.02
- Revenue Growth
- ORMP N/A
- CTMX 18.01
- 52 Week Low
- ORMP $1.82
- CTMX $0.40
- 52 Week High
- ORMP $3.09
- CTMX $3.10
- Technical
- Relative Strength Index (RSI)
- ORMP 59.64
- CTMX 43.94
- Support Level
- ORMP $2.17
- CTMX $2.04
- Resistance Level
- ORMP $2.45
- CTMX $2.16
- Average True Range (ATR)
- ORMP 0.07
- CTMX 0.12
- MACD
- ORMP 0.02
- CTMX 0.00
- Stochastic Oscillator
- ORMP 61.76
- CTMX 18.42
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.